Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Gains from Investment Securities (2018 - 2025)

Dna X filings provide 8 years of Gains from Investment Securities readings, the most recent being -$122000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 168.93% to -$122000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$103000.0, a 114.63% decrease, with the full-year FY2025 number at $6991.0, down 83.3% from a year prior.
  • Gains from Investment Securities hit -$122000.0 in Q4 2025 for Dna X, down from $36360.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.5 million in Q3 2023 to a low of -$166000.0 in Q4 2023.
  • Median Gains from Investment Securities over the past 5 years was $84596.0 (2021), compared with a mean of $339444.4.
  • Biggest five-year swings in Gains from Investment Securities: surged 125200.0% in 2023 and later crashed 168.93% in 2025.
  • Dna X's Gains from Investment Securities stood at $42000.0 in 2021, then soared by 1530.95% to $685000.0 in 2022, then crashed by 124.23% to -$166000.0 in 2023, then skyrocketed by 206.63% to $177000.0 in 2024, then crashed by 168.93% to -$122000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were -$122000.0 (Q4 2025), $36360.0 (Q3 2025), and $675779.0 (Q2 2025) per Business Quant data.